Novel Coronavirus-induced Lung Fibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-03
Clinical Trial Update: Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia [Phase 4]
A Phase 4 trial comparing pirfenidone and nintedanib for fibrotic lung disease following COVID-19 pneumonia.